MRI in McArdle Disease (GSDV)

Glycogen Storage Disease Type V Clinical Trial

Official title:
MRI in McArdle Disease (Glycogen Storage Disease Type V)

Status Completed

Clinical Trial Summary

The aim of this study is to describe the degree of muscle wasting in patients with McArdle disease judged by MRI, quantitative magnetic resonance (DIXON) and T1 weighted images, and muscle strength, collected across multiple European sites and compared to healthy controls.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03844022
Study type	Observational
Source	Rigshospitalet, Denmark
Contact
Status	Completed
Phase
Start date	March 1, 2018
Completion date	February 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02919631` - Triheptanoin in Mc Ardle	Phase 2
Active, not recruiting	`NCT02635269` - Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy	N/A
Completed	`NCT03112889` - Sodium Valproate for GSDV	Phase 2
Withdrawn	`NCT02385162` - Biomarker for Glycogen Storage Diseases (BioGlycogen)
Completed	`NCT02432768` - The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)	Phase 2